Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.9%

44 terminated/withdrawn out of 889 trials

Success Rate

89.5%

+3.0% vs industry average

Late-Stage Pipeline

11%

102 trials in Phase 3/4

Results Transparency

1 of 374 completed trials have results

Key Signals

111 recruiting1 with results40 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

408(68.9%)

Phase 2

57(9.6%)

Phase 4

56(9.5%)

Phase 3

46(7.8%)

Phase 1

25(4.2%)

592Total

N/A(408)

Phase 2(57)

Phase 4(56)

Phase 3(46)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (889)

Showing 20 of 889 trials

NCT07569939Not ApplicableNot Yet Recruiting

Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral Tonsillitis

Role: lead

NCT07564609Enrolling By Invitation

the REMONO-CD and the REMONO-UC Studies

Role: lead

NCT07308067Active Not Recruiting

Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)

Role: lead

NCT06238570Not ApplicableRecruiting

Validation of Donor Oocytes Semi-automated Vitrification

Role: lead

NCT05928091Not ApplicableActive Not Recruiting

Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.

Role: lead

NCT05719844Not ApplicableRecruiting

Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players

Role: lead

NCT06497712Not ApplicableRecruiting

BEnefit of HYpnosis on Pain During Stitches in Emergency Room

Role: lead

NCT07179276Not ApplicableRecruiting

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

Role: lead

NCT06917651Phase 3Recruiting

Management of Moderate to Severe Monotraumatic Pain With Sublingual Sufentanil in an Emergency Situation.

Role: lead

NCT07330856Phase 4Recruiting

Evaluation of Treatments for Dry or Productive Cough

Role: lead

NCT07205731Phase 2Recruiting

Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma

Role: lead

NCT07545512Not ApplicableNot Yet Recruiting

ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY

Role: lead

NCT02819778Not ApplicableCompleted

Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury

Role: lead

NCT01602185Phase 2Completed

Study of NMDA Antagonists and Neuropathic Pain

Role: lead

NCT02618720Phase 3Completed

Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery

Role: lead

NCT02555982Phase 3Completed

Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor

Role: lead

NCT02149589Not ApplicableCompleted

Lung Imaging for Ventilatory Setting in ARDS

Role: lead

NCT02973542Phase 2Completed

Ethosuximide to Treat IBS

Role: lead

NCT04235608Phase 3Completed

SEvoflurane for Sedation in ARds